Anti-obesity effect of a hop-derived prenylflavonoid isoxanthohumol in a high-fat diet-induced obese mouse model.

Akkermansia hop isoxanthohumol microbiome obesity

Journal

Bioscience of microbiota, food and health
ISSN: 2186-6953
Titre abrégé: Biosci Microbiota Food Health
Pays: Japan
ID NLM: 101578264

Informations de publication

Date de publication:
2020
Historique:
received: 02 11 2019
accepted: 10 03 2020
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 11 8 2020
Statut: ppublish

Résumé

We examined whether oral administration of a hop-derived prenylflavonoid isoxanthohumol (IX) would show anti-obesity activity and the underlying mechanism of the potential activity using a high-fat diet (HFD)-induced obese mouse model. Oral administration of 180 mg/kg IX for 8 weeks suppressed HFD-induced accumulation of visceral fat and body weight gain in mice. Simultaneously, IX changed the composition of the microbiome, as determined by a significant increase in the relative abundances of

Identifiants

pubmed: 32775137
doi: 10.12938/bmfh.2019-040
pii: 2019-040
pmc: PMC7392919
doi:

Types de publication

Journal Article

Langues

eng

Pagination

175-182

Informations de copyright

©2020 BMFH Press.

Références

Cancer Sci. 2018 Jan;109(1):132-140
pubmed: 29121426
Nat Med. 2019 Jul;25(7):1096-1103
pubmed: 31263284
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84
pubmed: 17210919
Molecules. 2016 May 11;21(5):
pubmed: 27187329
Int J Obes Relat Metab Disord. 2002 Nov;26(11):1459-64
pubmed: 12439647
J Agric Food Chem. 1999 Jun;47(6):2421-8
pubmed: 10794646
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:59-63
pubmed: 24251706
Circulation. 2004 Jan 27;109(3):433-8
pubmed: 14744958
Curr Opin Investig Drugs. 2007 Apr;8(4):312-7
pubmed: 17458181
Clin J Am Soc Nephrol. 2007 May;2(3):550-62
pubmed: 17699463
FASEB J. 2010 Dec;24(12):4948-59
pubmed: 20724524
Eur J Clin Nutr. 2017 Sep;71(9):1040-1045
pubmed: 28589947
NPJ Biofilms Microbiomes. 2019 Oct 4;5:28
pubmed: 31602309
PLoS One. 2010 Feb 05;5(2):e9085
pubmed: 20140211
Science. 2013 Sep 6;341(6150):1241214
pubmed: 24009397
Nat Med. 2017 Jan;23(1):107-113
pubmed: 27892954
Gut. 2016 Mar;65(3):426-36
pubmed: 26100928
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Int J Obes (Lond). 2011 Jul;35(7):891-8
pubmed: 20975725
ISME J. 2013 Apr;7(4):880-4
pubmed: 23235292
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Biosci Biotechnol Biochem. 2018 Sep;82(9):1591-1598
pubmed: 29804513
JRSM Cardiovasc Dis. 2016 Feb 25;5:2048004016633371
pubmed: 26998259
Hepatology. 2011 Mar;53(3):821-32
pubmed: 21319201
Epigenetics. 2017 Jan 2;12(1):55-69
pubmed: 27858497
Biochim Biophys Acta Gene Regul Mech. 2019 Feb;1862(2):141-152
pubmed: 30605728
BMC Gastroenterol. 2015 Aug 11;15:100
pubmed: 26261039
J Biol Chem. 2015 Aug 14;290(33):20565-79
pubmed: 26140926
Br J Nutr. 2018 Nov;120(9):1014-1022
pubmed: 30355393
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927
Prev Med. 2014 May;62:167-78
pubmed: 24534460

Auteurs

Shinya Fukizawa (S)

Research Institute, Suntory Global Innovation Center Ltd., 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan.

Mai Yamashita (M)

Research Institute, Suntory Global Innovation Center Ltd., 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan.

Ken-Ichi Wakabayashi (KI)

Research Institute, Suntory Global Innovation Center Ltd., 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan.

Shiho Fujisaka (S)

1st Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan.

Kazuyuki Tobe (K)

1st Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan.

Yuji Nonaka (Y)

Research Institute, Suntory Global Innovation Center Ltd., 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan.

Norihito Murayama (N)

Research Institute, Suntory Global Innovation Center Ltd., 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan.

Classifications MeSH